前のページに戻る
この文献は全文を取り寄せることができます
JDreamⅢ複写サービスから文献全文の複写（冊子体のコピー）をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方
JDreamⅢ複写サービスのご利用が初めての方
取り寄せる文献のタイトルと詳細
文献
J-GLOBAL ID：202202239964987696
整理番号：22A0945694
アンギオポエチン-2血漿レベルの早期調節は転移性結腸直腸癌患者におけるレゴラフェニブからの利益を予測する【JST・京大機械翻訳】
Early modulation of Angiopoietin-2 plasma levels predicts benefit from regorafenib in patients with metastatic colorectal cancer
Antoniotti Carlotta
(Unity of Oncology, University Hospital of Pisa, Pisa, Italy)
,
Antoniotti Carlotta
(Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy)
,
Marmorino Federica
(Unity of Oncology, University Hospital of Pisa, Pisa, Italy)
,
Marmorino Federica
(Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy)
,
Boccaccino Alessandra
(Unity of Oncology, University Hospital of Pisa, Pisa, Italy)
,
Boccaccino Alessandra
(Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy)
,
Martini Silvia
(Molecular Pharmacology Unit, Department of Applied Research and Technological Development, National Cancer Institute of Milan, Milan, Italy)
,
Antista Maria
(Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy)
,
Rossini Daniele
(Unity of Oncology, University Hospital of Pisa, Pisa, Italy)
,
Rossini Daniele
(Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy)
,
Zuco Valentina
(Molecular Pharmacology Unit, Department of Applied Research and Technological Development, National Cancer Institute of Milan, Milan, Italy)
,
Prisciandaro Michele
(Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy)
,
Conca Veronica
(Unity of Oncology, University Hospital of Pisa, Pisa, Italy)
,
Conca Veronica
(Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy)
,
Zucchelli Gemma
(Unity of Oncology, University Hospital of Pisa, Pisa, Italy)
,
Zucchelli Gemma
(Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy)
,
Borelli Beatrice
(Unity of Oncology, University Hospital of Pisa, Pisa, Italy)
,
Borelli Beatrice
(Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy)
,
Cosentino Paola
(Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy)
,
Germani Marco M.
(Unity of Oncology, University Hospital of Pisa, Pisa, Italy)
,
Germani Marco M.
(Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy)
,
Bosco Maria F.
(Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy)
,
Carullo Martina
(Unity of Oncology, University Hospital of Pisa, Pisa, Italy)
,
Carullo Martina
(Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy)
,
Vetere Guglielmo
(Unity of Oncology, University Hospital of Pisa, Pisa, Italy)
,
Vetere Guglielmo
(Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy)
,
Moretto Roberto
(Unity of Oncology, University Hospital of Pisa, Pisa, Italy)
,
Moretto Roberto
(Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy)
,
Giordano Mirella
(Unity of Oncology, University Hospital of Pisa, Pisa, Italy)
,
Giordano Mirella
(Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy)
,
Masi Gianluca
(Unity of Oncology, University Hospital of Pisa, Pisa, Italy)
,
Masi Gianluca
(Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy)
,
Pietrantonio Filippo
(Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy)
,
Zaffaroni Nadia
(Molecular Pharmacology Unit, Department of Applied Research and Technological Development, National Cancer Institute of Milan, Milan, Italy)
,
Cremolini Chiara
(Unity of Oncology, University Hospital of Pisa, Pisa, Italy)
,
Cremolini Chiara
(Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy)
資料名：
European Journal of Cancer
(European Journal of Cancer)
巻： 165 ページ： 116-124 発行年： 2022年
JST資料番号： A0802C ISSN： 0959-8049 資料種別： 逐次刊行物 (A)
記事区分： 原著論文 発行国： オランダ (NLD) 言語： 英語 (EN)
JDreamⅢ複写サービスとは
JDreamⅢ複写サービスは、学術文献の全文を複写（コピー）して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写（コピー）は郵送またはFAXでお送りします
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。